Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor designed to act as a "decoy" or "scavenger" by targeting Fc and FcγR, binding and neutralizing pathogenic IgG. Its utility lies in mitigating the impact of autoimmune diseases, making it a focus in systemic lupus erythematosus (SLE) research [1].
説明 | Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor designed to act as a "decoy" or "scavenger" by targeting Fc and FcγR, binding and neutralizing pathogenic IgG. Its utility lies in mitigating the impact of autoimmune diseases, making it a focus in systemic lupus erythematosus (SLE) research [1]. |
別名 | BAX1810, TAK-752 |
分子量 | N/A |
CAS No. | 1804910-11-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valziflocept 1804910-11-9 BAX1810 TAK-752 Inhibitor inhibitor inhibit